At the mRNA Health conference in Berlin, enginzyme and AGC Inc. presented a scalable process to produce a key mRNA vaccine and therapy ingredient, N1-methylpseudouridine-5'-triphosphate (m (1) TP).
A more effective vaccine technology may be on the horizon. In a new study in mice, researchers from the University of Copenhagen demonstrate that a simple addition to mRNA vaccines can significantly ...
Live Science on MSN
An experimental mRNA treatment counters immune cell aging in mice
A trio of mRNA molecules could help guard against the harmful effects of aging on immune cells, a study in mice finds. A new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback